Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?-Reference-Cited by-同舟云学术

Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?

Published:2014-03-07 Issue:10 Volume:55 Page:2356-2361
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Laskar Siddhartha,Kumar Deepak P.,Khanna Nehal,Menon Hari,Sengar Manju,Arora Brijesh,Gujral Sumeet,Shet Tanuja,Sridhar Epari,Rangarajan Venkatesh,Muckaden Mary Ann,Nair Reena,Banavali Shripad

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.871631

Reference21 articles.

1. Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials

2. Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

3. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric Impact of Voluntary Deep Inspiration Breath Hold (DIBH) in Mediastinal Hodgkin Lymphomas: A Comparative Evaluation of Three Different Intensity Modulated Radiation Therapy (IMRT) Delivery Methods Using Voluntary DIBH and Free Breathing Techniques;Cancers;2024-02-06

2. Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH;Blood Advances;2023-10-13

3. Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience;Clinical and Translational Radiation Oncology;2022-07

4. Combined modality treatment: Outcome in patients with Hodgkin's lymphoma;Journal of Cancer Research and Therapeutics;2020

5. Hodgkin Lymphoma;Radiation Therapy in Hematologic Malignancies;2016-10-28